NCT04734535View on ClinicalTrials.gov

Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

February 5, 2024

Study Completion Date

February 5, 2024

Conditions
Surgical Bleeding
Interventions
DEVICE

HEMOBLAST™ Bellows

Intraoperative bleeding during epidural spine surgery will be treated with HEMOBLAST™ Bellows

DEVICE

absorbable gelatin sponge with thrombin

Intraoperative bleeding during epidural spine surgery will be treated with absorbable gelatin sponge with thrombin

Trial Locations (5)

13225

Indiana Spine Group, Carmel

21224

Johns Hopkins Bayview Medical Center, Baltimore

24511

Spectrum Medical Inc, Danville

900033

University of Southern California, Los Angeles

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Syneos Health
All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Dilon Technologies Inc.

INDUSTRY